Published in Immunology on October 01, 1970
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
Regulation of the immune response. V. An analysis of the function of the Fc portion of antibody in suppression of an immune response with respect to interaction with components of the lymphoid system. Immunology (1971) 1.24
Regulation of the immune response. VI. Inability of F(ab') 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression. Immunology (1973) 1.09
The dual affinity of a mycobacterial glycopeptide for sheep erythrocyte membranes and guinea-pig gamma-globulin. Immunology (1973) 0.87
Developed M haemolytic plaque-forming cells in chickens. Immunology (1973) 0.80
Normal human IgG with antibody activity for keyhole limpet haemocyanin. Immunology (1973) 0.80
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56
A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis (1959) 22.10
HOMEOSTASIS OF ANTIBODY FORMATION IN THE ADULT RAT. J Exp Med (1964) 6.03
The adsorption of antigen by spleen cells previously treated with antiserum in vitro. Immunology (1960) 5.82
The mechanism of immunological paralysis. Adv Immunol (1968) 5.53
Passive sensitization of lymphocytes and macrophages by antigen-antibody complexes. Proc Natl Acad Sci U S A (1965) 3.83
Properties of macrophage receptors for cytophilic antibodies. Br J Exp Pathol (1966) 2.07
Regulation of the immune response. I. Reduction in ability of specific antibody to inhibit long-lasting IgG immunological priming after removal of the Fc fragment. J Exp Med (1969) 1.93
Low zone tolerance to bacterial flagellin in adult rats: a possible role for antigen localized in lymphoid follicles. Proc Natl Acad Sci U S A (1968) 1.81
Symposium on in vitro studies of the immune response. I. Variations in the immune response to a simple determinant. Bacteriol Rev (1966) 1.65
Cytophilic antibodies in passive aibody induced immune suppression or enhancement. Nature (1970) 1.12
COFACTOR AND SPECIFIC ANTIBODIES AGAINST INFLUENZA VIRUSES. XI. MECHANISM OF THE ACTION OF ANTIBODY COFACTOR. Acta Virol (1965) 1.01
The fate of antigen and its relationship to the immune response. The complexity of antigens. Antibiot Chemother (1969) 0.96
The characterization of the immunological memory of the IgM type of response in chickens. Folia Biol (Praha) (1966) 0.87
The dose of antigen required for the suppression of the IgM and IgG antibody response in chickens. I. The kinetics and characterization of serum antibodies. Folia Biol (Praha) (1966) 1.32
Immunoglobulin synthesis and lymphocyte transformation by anti-immunoglobulin sera in bursectomized chickens. Immunology (1969) 1.29
Cytophilic antibodies in passive aibody induced immune suppression or enhancement. Nature (1970) 1.12
Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles. Leukemia (2009) 0.99
The significance of the dose of antien in immunity and tolerance. Curr Top Microbiol Immunol (1969) 0.95
High-dose delay of the immune response. Effect of actinomycin D on continuation of the immune response in vitro. J Exp Med (1968) 0.92
The dose of antigen required for the suppression of the IgM and IgG antibody response in chickens. II. Studies at the cellular level. Folia Biol (Praha) (1966) 0.90
The characterization of the immunological memory of the IgM type of response in chickens. Folia Biol (Praha) (1966) 0.87
Impairment of humoral antibody response in neonatally thymectomized and irradiated chickens. Eur J Immunol (1971) 0.86
Septicaemia due to acinetobacter strains. Zentralbl Bakteriol Orig A (1971) 0.82
The effect of protein antigen dosage on its elimination from the blood and organs. Folia Biol (Praha) (1965) 0.82
The nature of the delay in the immune response after administration of large doses of protein antigen in chicks. Folia Biol (Praha) (1965) 0.81
Common antigenic specificity on the H-chains of chicken IgM and IgG. Immunochemistry (1969) 0.80
Role of emotional factors in diabetes. Acta Diabetol Lat (1990) 0.78
A method for detection of doxorubicin-induced cardiotoxicity: Flow-mediated vasodilation of the brachial artery. Exp Clin Cardiol (2001) 0.78
Participation of 7S and 19S antibodies in enhancement and resistance to methylcholanthrene-induced tumours. Folia Biol (Praha) (1965) 0.77
The immunological significance of taxonomic origin of protein antigen in chickens. Folia Biol (Praha) (1966) 0.77
Stimulation of chicken lymphocytes in vitro by anti-immunoglobulin sera. Folia Biol (Praha) (1970) 0.77
Stimulation of DNA synthesis in the culture of mouse spleen cells by means of heterologous antilymphocytic and antiglobulin sera. Folia Biol (Praha) (1968) 0.77
The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement. Leukemia (2000) 0.76
[Bacterium anitratum infections in our patients]. Zentralbl Bakteriol Orig (1966) 0.76
[Again (?): the quality of life of hypertensive patients]. Orv Hetil (1994) 0.75
[Nothing is new under the sun]. Orv Hetil (1997) 0.75
Observations with captopril (Tensiomin) treatment in hypertensive patients (one-year period). Ther Hung (1989) 0.75
[Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring]. Orv Hetil (1996) 0.75
[Intramuscular strophanthin therapy]. Z Arztl Fortbild (Jena) (1965) 0.75
[Experiences with ethacrynic acid (Edecrin)]. Ther Ggw (1969) 0.75
[Experiences with dextran infusion treatment of acute thrombophlebitis]. Med Welt (1969) 0.75
[Rare types of acute pancreatitis]. Med Klin (1970) 0.75
Enhancement of antibody synthesis in vitro by 6-azauridine, uridine and actinomycin D. Folia Biol (Praha) (1970) 0.75
[Clinical and pathologic description of stroke patients (1990-1994)]. Orv Hetil (1999) 0.75
[Let's use correct Latin!]. Orv Hetil (2001) 0.75
Clinical experiences with Uregyt. Ther Hung (1970) 0.75
[Abuse of steroids]. Orv Hetil (1969) 0.75
Co-expression of c-abl and c-myb oncogenes in Philadelphia chromosome-negative, bcr-negative chronic myeloid leukaemia. Leuk Res (1994) 0.75
[Leptospirosis in South-East Hungary]. Med Welt (1973) 0.75
[Preventive treatment in internal medicine by low-molecular-weight heparin (nadroparine calcium)]. Orv Hetil (1998) 0.75
[The anti-lipidemic effect of Minipress]. Orv Hetil (1990) 0.75
[Guiding principles in the differential diagnosis of our icterus patients]. Landarzt (1964) 0.75
[Flavobacterium infections]. Orv Hetil (1967) 0.75
[The splenogram in acute viral hepatitis]. Acta Hepatosplenol (1968) 0.75
Experiences in patients treated with Visken. Ther Hung (1980) 0.75
Long-term Viskaldix therapy in the treatment of hypertensive patients. Ther Hung (1985) 0.75
[Labetalol: a new alpha/beta-adrenergic receptor blocking agent]. Orv Hetil (1981) 0.75
[The treatment of our patients with dysentery]. Ther Ggw (1966) 0.75
[ECG studies during esophagogastroduodenoscopy]. Z Gastroenterol (1977) 0.75
[Insulin-induced lipoatrophy--caused by monocomponent insulin?]. Orv Hetil (1989) 0.75
[The Framingham study, the 1st 10 years]. Orv Hetil (1971) 0.75
History of patients with chronic granulocytic leukaemia observed in 1974-1984. Acta Med Hung (1986) 0.75
[Problems of our diabetic rural workers]. Landarzt (1964) 0.75
[Cholecystectomy in diabetes melitus]. Med Klin (1973) 0.75
[Socio-medical aspects of diabetes mellitus in old age. Experience in southeast Hungary]. Z Psychosom Med Psychoanal (1981) 0.75
[Experience with diabetic patients in various surgical situations]. Acta Diabetol Lat (1969) 0.75
[Have autopsies become superfluous today?]. Med Klin (Munich) (1986) 0.75
[Analysis of the clinical course of chronic granulocytic leukemia in patients observed over a 10-year period (1974-1984)]. Orv Hetil (1986) 0.75
[Lasix, a new saluretic]. Orv Hetil (1966) 0.75
Characterization of antibodies and the histological study of skin graft destruction with heterologous antisera. Folia Biol (Praha) (1966) 0.75
[Six-year follow up on recently diagnosed NIDDM patients]. Orv Hetil (1995) 0.75
[A rapid rectoscopic method]. Orv Hetil (1966) 0.75
[Clinical evaluation of autopsy in the aged]. Z Gerontol (1987) 0.75
[Guiding principles in the differential diagnosis of jaundice in our clinical cases]. Z Allgemeinmed (1964) 0.75
[Experiences, problems and tasks in the field of diabetic care]. Dtsch Med J (1966) 0.75
[Reducing the incidence of fatal pulmonary embolism by preventive administration of heparin]. Orv Hetil (1993) 0.75
[Transient deafness during ethacrynic acid therapy]. Orv Hetil (1971) 0.75
[Positive and negative sides in the management of diabetics]. Orv Hetil (1988) 0.75
Observations with Viskaldix, a combined antihypertensive agent. Ther Hung (1987) 0.75
[Diabetic ketoacidosis (169 episodes in 131 patients in the course of 10 years)]. Orv Hetil (1991) 0.75
[On the problem of leptospirosis in Hungary]. Med Klin (1965) 0.75
[Personality studies in patients with insulin-dependent diabetes mellitus]. Orv Hetil (1986) 0.75
[Diabetes mellitus and surgery from the viewpoint of the internist]. Orv Hetil (1982) 0.75
[Angiologic aspects of surgery of the extremities in diabetics]. Orv Hetil (1990) 0.75